Nilai Prognostik Parameter Hematologi Rutin pada Pasien dengan Kanker Padat : Sebuah Tinjauan Sistematis
Keywords:
NLR, PLR, LMR, tumor solid, prognosis, biomarker inflamasiAbstract
Latar Belakang: Respons inflamasi sistemik memainkan peran kunci dalam progresi kanker. Parameter hematologi rutin seperti Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), dan Lymphocyte-to-Monocyte Ratio (LMR) telah muncul sebagai biomarker prognosis potensial yang murah dan mudah diakses.
Metode: Tinjauan sistematis ini dilakukan dengan mensintesis bukti dari 200 studi meta-analisis dan penelitian observasional besar yang mengevaluasi nilai prognosis parameter hematologi pada pasien dengan berbagai jenis tumor solid. Pencarian literasis dilakukan secara komprehensif. Data mengenai jenis parameter, nilai cut-off, luaran klinis (overall survival/OS, progression-free survival/PFS), dan konteks pengobatan diekstraksi dan dianalisis secara naratif.
Hasil: Neutrophil-to-Lymphocyte Ratio (NLR) merupakan parameter yang paling banyak diteliti dan secara konsisten terbukti sebagai prediktor independen untuk luaran yang lebih buruk pada berbagai keganasan, termasuk kanker kolorektal (HR 1,92 untuk OS), payudara (HR 2,56 untuk OS), paru (HR 1,46 untuk OS), ovarium (HR 1,69 untuk OS), dan urothelial (HR 1,72 untuk OS). Platelet-to-Lymphocyte Ratio (PLR) dan LMR juga menunjukkan nilai prognosis yang signifikan pada berbagai jenis kanker. Nilai cut-off sangat bervariasi, dengan NLR 3-5 dan PLR 150-200 sebagai batas yang umum digunakan. Yang penting, perubahan dinamis parameter ini selama pengobatan (misalnya, pada minggu ke-6 atau 12) seringkali memberikan informasi prognosis yang lebih unggul daripada nilai dasar saja, terutama pada pasien yang menerima imunoterapi dan terapi target.
Diskusi: Parameter hematologi mencerminkan keseimbangan antara inflamasi pro-tumor (neutrofil, trombosit) dan imunitas anti-tumor (limfosit). Kekuatan prognostiknya bervariasi tergantung pada jenis kanker, stadium, dan modalitas terapi, dengan efek yang paling kuat terlihat pada pengobatan imunoterapi. Meskipun hasilnya menjanjikan, standardisasi nilai cut-off dan waktu pengukuran sangat diperlukan sebelum implementasi klinis rutin.
Kesimpulan: Parameter hematologi rutin, terutama NLR, PLR, dan LMR, merupakan biomarker prognosis yang berharga pada pasien tumor solid. Pengukurannya yang sederhana dan murah dapat membantu stratifikasi risiko, memandu keputusan klinis, dan memantau respons terapi. Penelitian prospektif dengan metodologi terstandar diperlukan untuk mengintegrasikan biomarker ini ke dalam praktik klinis sehari-hari.
References
Jie Zhang, Hong-Ying Zhang, Jia Li, et al (2017) The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis. OncoTarget. https://doi.org/10.18632/oncotarget.18575
Jingxu Sun, Xiaowan Chen, P. Gao, et al (2016) Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis. Disease Markers. https://doi.org/10.1155/2016/7862469
X. Qi, Jianjun Li, Han Deng, et al (2016) Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. OncoTarget. https://doi.org/10.18632/oncotarget.9942
Y. Shao, Bowei Wu, W. Jia, et al (2020) Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis. BMC Urology. https://doi.org/10.1186/s12894-020-00665-8
I. Lucca, P. Jichlinski, S. Shariat, et al (2016) The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis. European Urology Focus. https://doi.org/10.1016/j.euf.2015.03.001
Yu Yu, L. Qian, J. Cui (2017) Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients. Molecular and clinical oncology. https://doi.org/10.3892/mco.2017.1342
Qi-tao Huang, Lin Zhou, Wen-juan Zeng, et al (2017) Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Cellular Physiology and Biochemistry. https://doi.org/10.1159/000475911
Jiali Leng, Fei Wu, Lihui Zhang (2022) Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet−to−Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta−analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2022.734948
Peijun Zou, E. Yang, Zhengyu Li (2020) Neutrophil-to-lymphocyte ratio is an independent predictor for survival outcomes in cervical cancer: a systematic review and meta-analysis. Scientific Reports. https://doi.org/10.1038/s41598-020-79071-x
Pierluigi Mariani, D. Russo, Marco Maisto, et al (2021) Pre‐treatment neutrophil‐to‐lymphocyte ratio is an independent prognostic factor in head and neck squamous cell carcinoma: Meta‐analysis and trial sequential analysis. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.13264
Hariruk Yodying, A. Matsuda, M. Miyashita, et al (2016) Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-015-4869-5
H. Hamid, George N. Davis, M. Trejo-Ávila, et al (2021) Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis. Surgical oncology. https://doi.org/10.1016/j.suronc.2021.101556
Y. Shao, Wenxia Li, Dongwen Wang, Bowei Wu (2020) Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis. World Journal of Surgical Oncology. https://doi.org/10.1186/s12957-020-02048-7
J. Gong, Hui Jiang, C. Shu, et al (2019) Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis. Journal of Ovarian Research. https://doi.org/10.1186/s13048-019-0527-z
Benjamin A. Derman, J. Macklis, M. S. Azeem, et al (2017) Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer. BMC Cancer. https://doi.org/10.1186/s12885-017-3122-y
J. Ethier, D. Desautels, A. Templeton, et al (2017) Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Research. https://doi.org/10.1186/s13058-016-0794-1
Jae‐Keun Cho, Myoung Woo Kim, I. Choi, et al (2018) Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study. BMC Cancer. https://doi.org/10.1186/s12885-018-4876-6
Min Deng, Yun Qing, Dan Qiu, et al (2025) The prognostic value of pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with esophageal cancer undergoing immunotherapy: a systematic review and meta-analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2025.1536920
Lu Tang, Xintao Li, Baojun Wang, et al (2016) Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis. PLoS ONE. https://doi.org/10.1371/journal.pone.0153981
D. Lorente, J. Mateo, A. Templeton, et al (2015) Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use. Annals of Oncology. https://doi.org/10.1093/annonc/mdu587
X. Gu, T. Tian, Xiaoting Tian, Xiao-Jun Zhang (2015) Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis. Scientific Reports. https://doi.org/10.1038/srep12493
Suee Lee, S. Oh, Sung hyun Kim, et al (2013) Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer. https://doi.org/10.1186/1471-2407-13-350
Matthew Young, Jose C. Tapia, Bernadett Szabados, et al (2024) NLR Outperforms Low Hemoglobin and High Platelet Count as Predictive and Prognostic Biomarker in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. Clinical Genitourinary Cancer. https://doi.org/10.1016/j.clgc.2024.102072
D. B. Sacdalan, J. Lucero, D. Sacdalan (2018) Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis. OncoTargets and Therapy. https://doi.org/10.2147/OTT.S153290
N. Zhang, Jianjun Jiang, Sihui Tang, Gengyun Sun (2020) Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2020.106677
M. Kreuz, F. C. A. de Moraes, V. Sano, et al (2024) Association of baseline neutrophil-to-lymphocyte ratio and prognosis in melanoma patients treated with PD-1/PD-L1 blockade: a systematic review and meta-analysis. Melanoma research. https://doi.org/10.1097/CMR.0000000000001006
Donglan Liu, L. Heij, Z. Czigany, et al (2022) The prognostic value of neutrophil-to-lymphocyte ratio in cholangiocarcinoma: a systematic review and meta-analysis. Scientific Reports. https://doi.org/10.1038/s41598-022-16727-w
Xieyan Zhuang, Yan Li, Hongfeng Zheng, L. Fu (2024) Evaluating the prognostic relevance of neutrophil-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2024.1461175
A. Templeton, J. Knox, N. Mitchell, et al (2014) 817PPROGNOSTIC IMPACT OF CHANGE IN NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN RESPONSE TO TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA (MRCC). Annals of Oncology. https://doi.org/10.1093/annonc/mdu337.10
K. Mori, N. Miura, H. Mostafaei, et al (2020) Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-020-01690-1
Shan Lin, Shiping Hu, Y. Ran, Fenfang Wu (2021) Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis. Translational Cancer Research. https://doi.org/10.21037/tcr-20-3237
Chunhua Xu, Fenfang Wu, Lailing Du, et al (2023) Significant association between high neutrophil-lymphocyte ratio and poor prognosis in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1211399
Jian-Guo Zhou, A. Wong, Haitao Wang, et al (2021) 329 Early blood cell count test (BCT) for survival prediction for non-small cell lung cancer patients treated with atezolizumab: integrated analysis of 4 multicenter clinical trials. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2021-sitc2021.329
(2021) 362 Association of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with clinical outcomes to tislelizumab monotherapy in patients with previously treated advanced hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2021-sitc2021.362
T. Nishijima, H. Muss, S. S. Shachar, et al (2015) Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2015.10.003
Abdullah M. Alshahrani, Kanwalpreet Kaur, Ravinder Saini, A. Heboyan (2025) Hematological parameters as predictors of oral cancer prognosis: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-025-06394-5
T. Yanagisawa, K. Mori, S. Katayama, et al (2022) Hematological prognosticators in metastatic renal cell cancer treated with immune checkpoint inhibitors: a meta-analysis. Immunotherapy. https://doi.org/10.2217/imt-2021-0207
Lixing Liu, Yange Gong, Qinglin Zhang, et al (2020) Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2019.01557
Liwei Ni, Jialong Tao, Jianhao Xu, et al (2019) Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-019-05372-w
I. G. S. Winata, I. W. A. S. Pradnyana, M. U. Yusrika, et al (2024) Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as an Early Prognostic Marker in Patients with Ovarian Cancer: A Systematic Review and Meta-Analysis. Asian Pacific Journal of Cancer Prevention. https://doi.org/10.31557/APJCP.2024.25.6.1921
Mu-xing Li, Xue‐min Liu, Xufeng Zhang, et al (2014) Prognostic role of neutrophil‐to‐lymphocyte ratio in colorectal cancer: A systematic review and meta‐analysis. International Journal of Cancer. https://doi.org/10.1002/ijc.28536
M. Vartolomei, D. Porav-Hodade, M. Ferro, et al (2018) Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis. Urologic oncology. https://doi.org/10.1016/j.urolonc.2018.05.014
C. Barbon, R. Velasco, D. B. Sacdalan, N. Maghuyop (2019) PROGNOSTIC SIGNIFICANCE OF HEMATOLOGIC BIOMARKERS IN SMALL CELL LUNG CANCER: A META-ANALYSIS AND SYSTEMATIC REVIEW. Chest. https://doi.org/10.1016/j.chest.2019.08.399
N. Mowbray, D. Griffith, M. Hammoda, et al (2018) A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection. HPB. https://doi.org/10.1016/j.hpb.2017.12.009
G. Portale, P. Bartolotta, D. Azzolina, et al (2023) Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: systematic review and meta-analysis. Langenbeck's archives of surgery (Print). https://doi.org/10.1007/s00423-023-02786-8
G. Malietzis, M. Giacometti, R. Kennedy, et al (2014) The Emerging Role of Neutrophil to Lymphocyte Ratio in Determining Colorectal Cancer Treatment Outcomes: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-014-3815-2
Zheng Xu, Cheng-jie Ye, Linxun Liu, et al (2018) The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysis. Biomarkers in Medicine. https://doi.org/10.2217/bmm-2017-0307
K. Wind, Johanne H Steffensen, A. V. Jakobsen, et al (2025) Prognostic significance of pre‐treatment immune‐inflammation biomarkers in anal cancer: A study combining real‐world data and a meta‐analysis. International Journal of Cancer. https://doi.org/10.1002/ijc.35404
P. Jarmużek, Klaudia Kozlowska, Piotr Defort, et al (2023) Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis. Cancers. https://doi.org/10.3390/cancers15133339
Yupeng Guan, Haiyun Xiong, Yupeng Feng, et al (2020) Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis. Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-020-0209-3
F. Savioli, E. Morrow, R. Dolan, et al (2022) Prognostic role of preoperative circulating systemic inflammatory response markers in primary breast cancer: meta-analysis. British Journal of Surgery. https://doi.org/10.1093/bjs/znac319
J. Ethier, D. Desautels, A. Templeton, et al (2017) Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2017.02.026
Jiawen Zhao, Weijia Huang, Yongxian Wu, et al (2020) Prognostic role of pretreatment blood lymphocyte count in patients with solid tumors: a systematic review and meta-analysis. Cancer Cell International. https://doi.org/10.1186/s12935-020-1094-5
D. Sit, R. Thomas, M. Giuliani, et al (2018) Can the Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) Predict Survival or Local Control in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC)? A Systematic Review. International Journal of Radiation Oncology, Biology, Physics. https://doi.org/10.1016/j.ijrobp.2018.07.1899
Rafael Bispo, Izabella Fernanda Bastos Siqueira, Bruno Felipe Santos de Oliveira, et al (2023) Prognostic value of the platelet-lymphocyte ratio for Glioblastoma: A systematic review. World Neurosurgery. https://doi.org/10.1016/j.wneu.2023.04.086
Hao Peng, Xiaogang Luo (2019) Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis. Cancer Cell International. https://doi.org/10.1186/s12935-019-0785-2
C. Dennehy, E. McMahon, D. Power, et al (2019) Clinical haematological biomarkers: Derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and prognostic nutritional index (PNI) and their relationship to survival outcomes in non small cell lung cancer (NSCLC) treated with immunotherapy: A multicenter review. Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2019.37.15_SUPPL.E20704
Fangyu Yang, Qianyi Huang, Zhongying Guan, Q. Diao (2020) Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in patients with laryngeal cancer: a systematic review and meta-analysis. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-020-06337-5
S. Martins, P. Miguel-Semedo, D. Martins-Branco, et al (2019) Hematological profile: A prognosis tool in melanoma patients treated with immunotherapy. Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2019.37.8_SUPPL.135
M. Papakonstantinou, Stylianos Fiflis, Gregory Christodoulidis, et al (2022) Neutrophil-to-lymphocyte ratio as a prognostic factor for survival in patients with colorectal liver metastases: A systematic review. World Journal of Clinical Oncology. https://doi.org/10.5306/wjco.v13.i10.822
Á. Széles, A. Kubik, S. Váncsa, et al (2025) Prognostic and predictive value of pre-treatment blood-based inflammatory biomarkers in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1554048
Sze Wah Samuel Chan, E. Smith, R. Aggarwal, et al (2021) Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2021.01.002
Ziqian Zhao, Haoyi Xu, Binlin Ma, Chao Dong (2025) Prognostic value of platelet to lymphocyte ratio (PLR) in breast cancer patients receiving neoadjuvant therapy: a systematic review and meta-analysis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1658571
G. Pirozzolo, S. Gisbertz, C. Castoro, et al (2019) Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis. Journal of Thoracic Disease. https://doi.org/10.21037/JTD.2019.07.30
J. Suh, J. Jung, C. Jeong, et al (2019) Clinical Significance of Pre-treated Neutrophil-Lymphocyte Ratio in the Management of Urothelial Carcinoma: A Systemic Review and Meta-Analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2019.01365
D. Szor, A. Dias, M. A. Pereira, et al (2018) Prognostic Role of Neutrophil/Lymphocyte Ratio in Resected Gastric Cancer: A Systematic Review and Meta-analysis. Clinics. https://doi.org/10.6061/clinics/2018/e360
A. Templeton, J. Knox, Xun Lin, et al (2016) Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy. European Urology. https://doi.org/10.1016/j.eururo.2016.02.033
C. Soronnadi, N. Ibeh, Francis O. Ugwene, et al (2020) The use of peripheral blood cells as an assessment of inflammation in prostate cancer in patients attending in surgery department at ESUT teaching hospital, Parklane, Enugu, Nigeria. International Journal of Research in Medical Sciences. https://doi.org/10.18203/2320-6012.ijrms20205824
Po-Li Tsai, W. Su, Wei-Hung Leung, et al (2016) Neutrophil-lymphocyte ratio and CEA level as prognostic and predictive factors in colorectal cancer: A systematic review and meta-analysis. Journal of Cancer Research and Therapeutics. https://doi.org/10.4103/0973-1482.144356
M. Vartolomei, S. Kimura, M. Ferro, et al (2018) Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients. World journal of urology. https://doi.org/10.1007/s00345-018-2235-5
Shufa Tan, Qin Zheng, Wei Zhang, et al (2024) Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2024.1408700
N. Clara, N. Ibeh, F. Ugwuene, et al (2022) Use the Complete Blood Counts and Esr as Biomarkers Prognostic Tool in Breast Cancer Patients Attending Surgery Department at Esut Teaching Hospital, Parklane Enugu Nigeria. Journal of Pharmaceutical Research International. https://doi.org/10.9734/jpri/2022/v34i39a36230
Linghao Meng, Yujia Yang, Xu Hu, et al (2023) Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis. Journal of Translational Medicine. https://doi.org/10.1186/s12967-023-03924-y
P. Ferrucci, S. Gandini, A. Battaglia, et al (2015) Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients. British Journal of Cancer. https://doi.org/10.1038/bjc.2015.180
Lijuan Ma, Fei Yang, Wentao Guo, et al (2024) Prognostic role of platelet-to-lymphocyte ratio in patients with rectal cancer undergoing resection: a systematic review and meta-analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2024.1415443
Ahmet Gulmez, H. Harputluoglu (2022) Advanced Hepatocellular Cancer Treated with Sorafenib and Novel Inflammatory Markers. Journal of Gastrointestinal Cancer. https://doi.org/10.1007/s12029-021-00789-6
J. Broto, Samuel Hidalgo, D. Moura, et al (2021) Inflammatory indexes neutrophils/lymphocytes, platelets/lymphocytes and red-cell distribution width (RDW) as prognostic biomarkers in advanced solitary fibrous tumors (SFT) treated with pazopanib: Correlative study of GEIS-32 trial. https://doi.org/10.1200/JCO.2021.39.15_SUPPL.11511
Di Zeng, Yaoqun Wang, Ningyuan Wen, et al (2024) The prognostic value of preoperative peripheral blood inflammatory biomarkers in extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2024.1437978
Irina Shevchenko, D. Șerban, Laurențiu Simion, et al (2025) Clinical Significance of Blood Cell-Derived Inflammation Markers in Assessing Potential Early and Late Postoperative Complications in Patients with Colorectal Cancer: A Systematic Review. Journal of Clinical Medicine. https://doi.org/10.3390/jcm14072529
C. Onal, A. M. Sedef, F. Kose, et al (2019) The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. Future Oncology. https://doi.org/10.1200/JCO.2019.37.7_SUPPL.308
Liling Huang, Shiyu Jiang, Yuankai Shi (2022) Prognostic significance of baseline neutrophil-lymphocyte ratio in patients with non-small-cell lung cancer: a pooled analysis of open phase III clinical trial data. Future Oncology. https://doi.org/10.2217/fon-2021-1304
C. Pisano, M. Tucci, R. F. Di Stefano, et al (2021) Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with Abiraterone or Enzalutamide. Minerva urology and nephrology. https://doi.org/10.23736/S2724-6051.21.04186-2
A. Sánchez-Gastaldo, Miguel A Muñoz-Fuentes, S. Molina-Pinelo, et al (2021) Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab. Translational Lung Cancer Research. https://doi.org/10.21037/tlcr-21-156
S. E. Rebuzzi, A. Signori, M. Stellato, et al (2022) The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2022.955501
Zimu Wang, P. Zhan, Yan-ling Lv, et al (2019) Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis. Translational Lung Cancer Research. https://doi.org/10.21037/TLCR.2019.06.10
Małgorzata Pienia̧żek, A. Polakiewicz-Gilowska, M. Las-Jankowska, et al (2025) Baseline hemoglobin and neutrophil-to-lymphocyte ratio as prognostic biomarkers in patients with metastatic triple negative breast cancer treated with sacituzumab govitecan in second line and beyond: a real-world analysis. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-025-07825-0
Xiuqiong Chen, F. Meng, R. Jiang (2021) Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2021.746976
Wei-qi Song, Chuan Tian, Kai Wang, et al (2017) Preoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer: A systematic review and meta-analysis. PLoS ONE. https://doi.org/10.1371/journal.pone.0178762
Jiayuan Wu, Manyu Chen, C. Liang, Wenmei Su (2017) Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review. OncoTarget. https://doi.org/10.18632/oncotarget.14541
Wanfu Lin, Maofeng Zhong, Yu-Ren Zhang, et al (2018) Prognostic Role of Platelet-to-Lymphocyte Ratio in Hepatocellular Carcinoma with Different BCLC Stages: A Systematic Review and Meta-Analysis. Gastroenterology Research and Practice. https://doi.org/10.1155/2018/5670949
I. Cho, J. Park, C. Park, et al (2014) Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer. Gastric Cancer. https://doi.org/10.1007/s10120-013-0330-2
R. V. Soest, A. Templeton, A. Templeton, et al (2015) Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. Annals of Oncology. https://doi.org/10.1093/annonc/mdu569
Xintao Li, Xin Ma, Lu Tang, et al (2016) Prognostic value of neutrophil-to-lymphocyte ratio in urothelial carcinoma of the upper urinary tract and bladder: a systematic review and meta-analysis. OncoTarget. https://doi.org/10.18632/oncotarget.17467
Shuangshuang Li, Xudong Feng, Guodong Cao, et al (2020) Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis. PLoS ONE. https://doi.org/10.1371/journal.pone.0230879
Jinxiang Peng, Haozhu Chen, Zhuang Chen, et al (2025) Prognostic value of neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma receiving curative therapies: a systematic review and meta-analysis. BMC Cancer. https://doi.org/10.1186/s12885-025-13972-w
G. Nogueira-Costa, I. Fernandes, R. Gameiro, et al (2020) Prognostic utility of neutrophil-to-lymphocyte ratio in patients with metastatic colorectal cancer treated using different modalities. Current Oncology. https://doi.org/10.3747/co.27.6573
J. Dauendorffer, B. Cavelier-Balloy, C. Renaud-Vilmer (2013) [Circumcision and dermatology]. Annales de dermatologie et de vénéréologie. https://doi.org/10.1016/j.annder.2013.06.008
Xuemin Wang, Shiqiang Su, Yuanshan Guo (2017) The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis. OncoTarget. https://doi.org/10.18632/oncotarget.21108
Matteo Santoni, U. Giorgi, R. Iacovelli, et al (2013) Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma. British Journal of Cancer. https://doi.org/10.1038/bjc.2013.522
Anup Patel, A. Ravaud, R. Motzer, et al (2019) MP25-17 NEUTROPHIL- AND PLATELET-TO-LYMPHOCYTE RATIOS AS PROGNOSTIC FACTORS OF DISEASE-FREE SURVIVAL IN HIGH-RISK RENAL CELL CARCINOMA. Journal of Urology. https://doi.org/10.1097/01.JU.0000555662.04204.2C
T. Yang, Lizheng Hao, Xinyu Yang, et al (2021) Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis. BMJ Open. https://doi.org/10.1136/bmjopen-2021-049123
A. Meisel, R. de Wit, S. Oudard, et al (2022) Neutropenia, neutrophilia, and neutrophil–lymphocyte ratio as prognostic markers in patients with metastatic castration-resistant prostate cancer. Therapeutic Advances in Medical Oncology. https://doi.org/10.1177/17588359221100022
Yongchao Zhang, Bozhi Liu, S. Kotenko, Wei Li (2022) Prognostic value of neutrophil-lymphocyte ratio and lactate dehydrogenase in melanoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Medicine. https://doi.org/10.1097/MD.0000000000029536
N. Zhao, Huilin Xu, Ding-gang Zhou, et al (2022) The prognostic role of neutrophil-to-lymphocyte ratio and C-reactive protein in metastatic colorectal cancer using regorafenib: a systematic review and meta-analysis. Journal of Gastrointestinal Oncology. https://doi.org/10.21037/jgo-22-683
(2016) Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer. OncoTarget. https://doi.org/10.18632/oncotarget.8901
K. Mori, F. Janisch, H. Mostafaei, et al (2020) Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis. Urologic oncology. https://doi.org/10.1016/j.urolonc.2020.01.015
Zhuo Yang, jiahui gu, Cuishan Guo, et al (2017) Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies. OncoTarget. https://doi.org/10.18632/oncotarget.16793
Abril Carrillo, Yenny Viviana Pinzón, Arantza Lizbeth Garcia Loera, et al (2025) Prognostic value of inflammatory markers in glioblastoma: A meta-analysis of NLR and PLR stratified by cutoff values. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2067
Lingyue Zhou, Xiaofeng Luo (2017) Platelet to lymphocyte ratio in biliary tract cancer: Review and meta-analysis. Clinica chimica acta; international journal of clinical chemistry. https://doi.org/10.1016/j.cca.2017.09.006
Zhe-wei Wei, Wei-Bin Huang, Dong-Jie Yang, et al (2020) The prognostic roles of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in gastrointestinal stromal tumours: a meta-analysis. Translational Cancer Research. https://doi.org/10.21037/tcr-20-1037
E. Dell'Aquila, C. Cremolini, T. Zeppola, et al (2017) Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO. Annals of Oncology. https://doi.org/10.1093/annonc/mdy004
Jing Jin, Lan Yang, Dan Liu, W. Li (2021) Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Lung Cancer: A Systematic Review and Meta-Analysis. Technology in Cancer Research and Treatment. https://doi.org/10.1177/1533033820983085
Urszula Rychlik, W. Szatkowski, Andrzej Kałamacki, et al (2024) Evaluation of inflammatory mediators as predictors ofprogression-free time (PFS) in patients with ovarian cancer(HGSOC) before and during treatment. Diagnostyka Laboratoryjna. https://doi.org/10.5604/01.3001.0054.9810
Li Huang, Wenke Wu, Ge Hu (2024) Prognostic value of platelet-to-lymphocyte ratio in patients with oral squamous cell carcinoma: a systematic review and meta-analysis. BMC Oral Health. https://doi.org/10.1186/s12903-024-05026-7
A. Horne, K. Mactier, T. Evans, et al (2019) EP1.18-07 Evaluation of Patient Outcomes Using Haematological Bio-Markers in Patients Undergoing Chemoradiation for Non Small Cell Lung Cancer. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2019.08.2452
R. O'Dwyer, C. Dennehy, J. Sui, et al (2019) Neutrophil to Lymphocyte ratio (NLR): A prognostic marker in melanoma patients receiving immunotherapy. Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2019.37.15_SUPPL.9573
Xinmin Zhao, Xianghua Wu, Hui Yu, et al (2022) Prognostic value of hematologic parameters in advanced non-small cell lung cancer patients receiving anti-PD-1 inhibitors. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2022.1003581
Yingchun Li, Chenyu Wang, Mengdan Xu, et al (2017) Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-016-2330-1
E. Petracci, A. Passardi, A. Biggeri, et al (2024) Baseline and Longitudinal Neutrophil-to-Lymphocyte Ratio as Prognostic Factor for Metastatic Colorectal Cancer: A Secondary Analysis of the ITACa Randomized Trial. JCO Precision Oncology. https://doi.org/10.1200/PO.23.00256
Ke Zhou, Jie Cao, Huahang Lin, et al (2022) Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2022.962173
G. Colloca, A. Venturino, D. Guarneri (2023) Neutrophil-to-lymphocyte ratio predicts survival of patients with rectal cancer receiving neo-adjuvant chemoradiation followed by radical resection: a meta-analysis. Expert Review of Anticancer Therapy. https://doi.org/10.1080/14737140.2023.2194635
J. Ventriglia, A. Petrillo, M. Álvaro, et al (2018) Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis. Gastroenterology Research and Practice. https://doi.org/10.1155/2018/2373868
Nan Chen, Wanling Li, Kexin Huang, et al (2017) Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies. OncoTarget. https://doi.org/10.18632/oncotarget.16020
Guoming Hu, Feng Xu, Kefang Zhong, et al (2018) The prognostic role of preoperative circulating neutrophil–lymphocyte ratio in primary bladder cancer patients undergoing radical cystectomy: a meta-analysis. World journal of urology. https://doi.org/10.1007/s00345-018-2593-z
Longwei Ma, Jiaxing He, Ping Li, et al (2025) Prognostic value of neutrophil to lymphocyte ratio in patients with esophagus cancer receiving neoadjuvant therapy: a systematic review and meta-analysis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1615962
M. Bilen, B. Rini, M. Voss, et al (2021) Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.CCR-21-1688
Qiong Zhou, Jie Dong, Qingqing Sun, et al (2021) Role of neutrophil-to-lymphocyte ratio as a prognostic biomarker in patients with breast cancer receiving neoadjuvant chemotherapy: a meta-analysis. BMJ Open. https://doi.org/10.1136/bmjopen-2020-047957
M. Krauthamer, K. Rouvinov, S. Ariad, et al (2013) A Study of Inflammation-Based Predictors of Tumor Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Oncology. https://doi.org/10.1159/000348385
J. Rodrigo, Mario Sánchez-Canteli, A. Triantafyllou, et al (2023) Neutrophil to Lymphocyte Ratio in Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Cancers. https://doi.org/10.3390/cancers15030802
G. Nogueira-Costa, I. Fernandes, R. Gameiro, et al (2020) Prognostic Utility of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Colorectal Cancer Treated Using Different Modalities. Current Oncology. https://doi.org/10.3747/co.27.6573
S. Clarke, M. burge, K. Feeney, et al (2020) The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT]. PLoS ONE. https://doi.org/10.1371/journal.pone.0229900
T. Biswas, Rohin Gawdi, Charulata Jindal, et al (2021) Pretreatment neutrophil-to-lymphocyte ratio as an important prognostic marker in stage III locally advanced non-small cell lung cancer: confirmatory results from the PROCLAIM phase III clinical trial. Journal of Thoracic Disease. https://doi.org/10.21037/jtd-21-1018
P. Vlachostergios, Aileen Lee, Charlene Thomas, et al (2019) Neutrophil-to-lymphocyte ratio as a prognostic biomarker for overall survival in men with advanced prostate cancer treated with platinum chemotherapy. Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2019.37.7_SUPPL.266
Qingtian Zhou, Zewen Jiang, Tingting Ye, et al (2025) Prognostic value of platelet-to-lymphocyte ratio in hepatocellular carcinoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. BMC Gastroenterology. https://doi.org/10.1186/s12876-025-04028-1
Yoshimasa Miyagawa, Ayako Yanai, T. Yanagawa, et al (2020) Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer. OncoTarget. https://doi.org/10.18632/oncotarget.27423
M. Boegemann, K. Schlack, Stefan Thomes, et al (2017) The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms18020380
Matteo Bauckneht, S. E. Rebuzzi, A. Signori, et al (2021) The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study). European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-021-05550-6
Shuiqing Wu, Q. Wan, Ran Xu, et al (2017) Systematic review and meta-analysis of the prognostic value of preoperative platelet-to-lymphocyte ratio in patients with urothelial carcinoma. OncoTarget. https://doi.org/10.18632/oncotarget.21162
Xue Qi, Jia Chen, Sheng Wei, et al (2023) Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis. BMJ Open. https://doi.org/10.1136/bmjopen-2023-074874
Xiaodong Sun, Xiao-ju Shi, Yuguo Chen, et al (2015) Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis. Gastroenterology Research and Practice. https://doi.org/10.1155/2016/4743808
Shuwen Lin, Yinghua Fang, Zhikang Mo, et al (2020) Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients. World Journal of Surgical Oncology. https://doi.org/10.1186/s12957-020-01962-0
J. Murray, Debra A G McIntyre, V. Anagnostou, et al (2023) Peripheral myeloid cells as prognostic markers in patients (pts) with non-small cell lung cancer (NSCLC) treated with cemiplimab: Pooled analysis of EMPOWER-Lung 1 and EMPOWER-Lung 3 phase 3 trials. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2023.41.16_suppl.9028
Ezgi Değerli, Ç. Arslan, F. Selçukbiricik, et al (2024) Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy. Medicina. https://doi.org/10.3390/medicina60122103
A. Casadei Gardini, E. Scarpi, M. Valgiusti, et al (2020) Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial. Therapeutic Advances in Medical Oncology. https://doi.org/10.1177/1758835920958363
D. Cao, Huilin Xu, Ximing Xu, et al (2018) A reliable and feasible way to predict the benefits of Nivolumab in patients with non-small cell lung cancer: a pooled analysis of 14 retrospective studies. Oncoimmunology. https://doi.org/10.1080/2162402X.2018.1507262
S. E. Rebuzzi, A. Signori, S. Buti, et al (2022) The prognostic value of peripheral blood inflammatory indices early variation in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with nivolumab (Δ-Meet-URO analysis). Journal of Clinical Oncology. https://doi.org/10.1200/jco.2022.40.16_suppl.4534
T. Feinstein, G. Legaspi, S. Duprez, et al (2023) Prognostic value of baseline immune suppressive biomarkers to select non-small cell lung cancer (NSCLC) patients (pts) likely to benefit from the plinabulin/docetaxel (Plin/Doc) combination. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2023.41.16_suppl.e21018
R. Wit, C. Wülfing, D. C. Gauna, et al (2020) 629P Neutrophil-lymphocyte ratio (NLR) as a prognostic and predictive biomarker in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with cabazitaxel (CBZ) vs abiraterone or enzalutamide in the CARD study. Annals of Oncology. https://doi.org/10.1016/j.annonc.2020.08.888
A. Farolfi, M. Petrone, E. Scarpi, et al (2018) Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24). Targeted oncology. https://doi.org/10.1007/s11523-018-0574-1
D. Schadendorf, K. Flaherty, H. Tawbi, et al (2022) 871P Predictive role of neutrophil-lymphocyte ratio (NLR) in patients (pts) with metastatic melanoma: A post hoc exploratory analysis from phase III COMBI-i trial. Annals of Oncology. https://doi.org/10.1016/j.annonc.2022.07.997
M. Bilen, B. Rini, R. Motzer, et al (2020) Association of neutrophil to lymphocyte ratio (NLR) with efficacy from JAVELIN Renal 101. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2020.38.15_suppl.5061
T. Loubersac, M. Nguilé-Makao, F. Pouliot, et al (2020) Neutrophil-to-lymphocyte Ratio as a Predictive Marker of Response to Abiraterone Acetate: A Retrospective Analysis of the COU302 Study. European Urology Oncology. https://doi.org/10.1016/J.EUO.2019.01.009
T. Zhuang, D. Ravindranathan, Yuan Liu, et al (2022) Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The Oncologist. https://doi.org/10.1093/oncolo/oyac236
A. Meisel, C. Parker, R. Kühne, et al (2020) 637P The prognostic value of the baseline neutrophil-to-lymphocyte ratio (NLR) in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving radium-223 (Ra-223): A post-hoc analysis of the ALSYMPCA phase-III trial. https://doi.org/10.1016/j.annonc.2020.08.896
Weiyu Xu, Jianping Xiong, Jianzhen Lin, et al (2018) Prognostic role of neutrophil-to-lymphocyte ratio in unresectable hepatocellular cancer patients treated with trans-arterial chemoembolization. Translational Cancer Research. https://doi.org/10.21037/23705
J. Fettiplace, B. Swift, Shu Zhang, et al (2022) Investigation of linerixibat 40mg BID for cholestatic pruritus of primary biliary cholangitis (PBC); further data from the phase 2b GLIMMER study to support the phase 3 GLISTEN study. Journal of Hepatology. https://doi.org/10.1016/s0168-8278(22)01034-0
Xiaofeng Luo, Lingyue Zhou (2018) Prognostic significance of neutrophil to lymphocyte ratio in patients with gastrointestinal stromal tumors: A meta-analysis. Clinica chimica acta; international journal of clinical chemistry. https://doi.org/10.1016/j.cca.2017.11.029
Miaomiao Gou, Yong Zhang (2022) Pretreatment platelet-to-lymphocyte ratio (PLR) as a prognosticating indicator for gastric cancer patients receiving immunotherapy. Discover Oncology. https://doi.org/10.1007/s12672-022-00571-5
A. Dirican, U. Varol, Y. Kucukzeybek, et al (2014) Treatment of metastatic colorectal cancer with or without bevacizumab: can the neutrophil/lymphocyte ratio predict the efficiency of bevacizumab? Asian Pacific Journal of Cancer Prevention. https://doi.org/10.7314/APJCP.2014.15.12.4781
Jiaguo Huang, Li Lin, Dikai Mao, et al (2024) Prognostic value of neutrophil-to-lymphocyte ratio in patients with non–muscle-invasive bladder cancer with intravesical Bacillus Calmette–Guérin immunotherapy: a systematic review and meta-analysis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2024.1464635
T.M. Vancea, A. O. Țăpîrdea, M. Zait, et al (2025) Baseline and Dynamic Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Metastatic Colorectal Cancer Patients Treated with Panitumumab. Journal of Personalized Medicine. https://doi.org/10.3390/jpm16010009
B. Shao, Xiao-ran Liu, Huiping Li, et al (2022) Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer. Current Oncology. https://doi.org/10.3390/curroncol29090483
D. Lorente, A. Templeton, O. Sartor, et al (2014) 787PASSOCIATION OF NEUTROPHIL-TO-LYMPHOCYTE RATIO (NLR) WITH SURVIVAL (OS) IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PATIENTS RECEIVING PREDNISONE (P) PLUS CABAZITAXEL (CBZ) OR MITOXANTRONE (MTX) IN THE TROPIC TRIAL. Annals of Oncology. https://doi.org/10.1093/annonc/mdu336.35
J. Duan, Linlin Pan, Ming-tian Yang (2018) Preoperative elevated neutrophil-to-lymphocyte ratio (NLR) and derived NLR are associated with poor prognosis in patients with breast cancer. Medicine. https://doi.org/10.1097/MD.0000000000013340
S. Fu, K. Chi (2018) Developing prognostic models for advanced prostate cancer when the goal line keeps changing. Annals of Oncology. https://doi.org/10.1093/annonc/mdy419
N. Na, Jia Yao, Cailian Cheng, et al (2016) Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors. OncoTarget. https://doi.org/10.18632/oncotarget.9836
Pengfei Wang, Huiying Jiang (2026) Prognostic value of systemic immune-inflammation index for colorectal cancer: a systematic review and meta-analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1616016
Yanfang Li, Juan Zhou, Hui Luo, et al (2025) Prognostic value of platelet to lymphocyte ratio in patients with colorectal cancer undergoing chemotherapy: a systematic review and meta-analysis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1642181
Ji-Feng Feng, Yanyan Wang, G. Shan, Lei Gao (2020) Clinical and prognostic value of neutrophil-lymphocyte ratio for patients with thyroid cancer. Medicine. https://doi.org/10.1097/MD.0000000000019686
Jinling Jiang, Tao Ma, Wen-qi Xi, et al (2019) Pre-treatment inflammatory biomarkers predict early treatment response and favorable survival in patients with metastatic colorectal cancer who underwent first line cetuximab plus chemotherapy. Cancer Management and Research. https://doi.org/10.2147/CMAR.S211089
R. Berardi, M. Santoni, S. Rinaldi, et al (2019) Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer. Annals of Translational Medicine. https://doi.org/10.21037/ATM.2019.09.18
Zijing Huang, Donghua Yang, Congrong Liu (2025) Prognostic value of lymphocyte-to-monocyte ratio in patients with endometrial cancer: an updated systematic review and meta-analysis. PeerJ. https://doi.org/10.7717/peerj.19345
N. Librenjak, Gordan Adžić, D. Kekez, et al (2026) Serial assessment of inflammatory biomarkers as a prognostic factor for first-line treatment outcomes in patients with metastatic colorectal cancer: single-center retrospective study. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1737930
D. Goldstein, R. El-Maraghi, P. Hammel, et al (2014) Analyses of updated overall survival (OS) and prognostic effect of neutrophil-to-lymphocyte ratio (NLR) and CA 19-9 from the phase III MPACT study of nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem for patients (pts) with metastatic pancreatic cancer (PC). https://doi.org/10.1200/JCO.2014.32.15_SUPPL.4027
Xing-mu Wang, X. Ni, Guiliang Tang (2019) Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2019.00757
S. Quesada, I. Ray-Coquard, C. Schiffler, et al (2024) 856 Routine baseline blood tests predicting pembrolizumab sensitivity in advanced high-grade serous ovarian cancer (AHGSOC) 1st line therapy: substudy from the NEOPEMBROV/GINECO (NCT03275506) randomized trial. Poster and E-Posters. https://doi.org/10.1136/ijgc-2024-esgo.728
T. Feinstein, Y. J. Lu, S. Duprez, et al (2023) Mechanism-based peripheral blood biomarkers to evaluate anticancer effects of the plinabulin/docetaxel combination (plin/doc) vs. doc alone in second/third line EGFR wild-type (WT) NSCLC. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2023.41.16_suppl.e21017
S. E. Rebuzzi, S. Buti, L. Galli, et al (2020) Baseline and early change of neutrophil to lymphocyte ratio (bNLR and ΔNLR) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: Preliminary results of the Meet-URO 15 (I-BIO-REC) study. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2020.38.6_suppl.752
Qian Liu, Y. Xi, Guangzhao He, et al (2021) Dynamics of neutrophil-to-lymphocyte ratio predict outcomes of metastatic colorectal carcinoma patients treated by FOLFOX. Journal of Gastrointestinal Oncology. https://doi.org/10.21037/jgo-21-716
G. Liposits, H. Skuladottir, J. Ryg, et al (2022) The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study. Journal of Clinical Medicine. https://doi.org/10.3390/jcm11195603
Ru-jin Hu, Qin Liu, Jianqiao Ma, et al (2018) Preoperative lymphocyte-to-monocyte ratio predicts breast cancer outcome: A meta-analysis. Clinica chimica acta; international journal of clinical chemistry. https://doi.org/10.1016/j.cca.2018.05.031
Ya-huan Guo, Hai-feng Sun, Yanbing Zhang, et al (2017) The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis. OncoTarget. https://doi.org/10.18632/oncotarget.15311
G. Holgersson, M. Bergqvist, J. Nilsson, et al (2017) The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial. Asian Pacific Journal of Cancer Prevention. https://doi.org/10.22034/APJCP.2017.18.6.1555
A. Russo, T. Franchina, G. Ricciardi, et al (2019) Dynamic changes of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lactate dehydrogenase (LDH) during treatment with immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2019.37.15_SUPPL.2596
Xunlei Zhang, Wenjing Zhao, Yang Yu, et al (2020) Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis. World Journal of Surgical Oncology. https://doi.org/10.1186/s12957-020-01952-2
Farima Safari, Seyed Ali Nabavizadeh, Atefeh Seghatoleslam, et al (2024) Systemic Immune-Inflammation Index (SII) as Prognostic Indicator for BCG Therapy in Bladder Cancer: A Systematic Review and Meta-analysis. Avicenna Journal of Medical Biochemistry. https://doi.org/10.34172/ajmb.2499
M. Takahashi, Kenichi Inoue, H. Mukai, et al (2021) Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan. Breast Cancer. https://doi.org/10.1007/s12282-021-01232-1
P. Mclellan, J. Henriques, F. Ksontini, et al (2020) Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma. Clinics And Research in Hepatology and Gastroenterology. https://doi.org/10.1016/j.clinre.2020.08.016
Zhan Wang, Xu Wang, Wen Wang, et al (2020) Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Predicting Prognosis of Surgically Resectable Urinary Cancers: Systematic Review and Meta-Analysis. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih. https://doi.org/10.24920/003668
Y. Nakazawa, Kanako Watanabe, Ako Gannichida, et al (2025) Significance of Neutrophil-to-Lymphocyte Ratio in Predicting the Efficacy of Anamorelin for Cancer Cachexia. Cureus. https://doi.org/10.7759/cureus.77795
J. Yin, Yuan Qin, Yukun Luo, et al (2017) Prognostic value of neutrophil-to-lymphocyte ratio for nasopharyngeal carcinoma. Medicine. https://doi.org/10.1097/MD.0000000000007577
Adam Burgoyne, A. Kaseb, Wei Shi, et al (2024) Role of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte-ratio (PLR) in unresectable hepatocellular carcinoma (uHCC): Subgroup analysis of patients treated with camrelizumab (cam) + rivoceranib (rivo) in the CARES-310 trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2024.42.16_suppl.e16197
D. Ciardiello, V. Famiglietti, S. Napolitano, et al (2022) Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival. Clinical colorectal cancer. https://doi.org/10.1016/j.clcc.2022.01.005
Hrishi Varayathu, R. Tiwari, S. Somayaji, et al (2021) Translational relevance of baseline NLR and LMR ratio in predicting response of EGFR-TKI. https://doi.org/10.1200/JCO.2021.39.15_SUPPL.E15020
N. Personeni, L. Giordano, G. Abbadessa, et al (2017) Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma. OncoTarget. https://doi.org/10.18632/oncotarget.14797
Gaowen Chen, Lin Zhu, Yulu Yang, et al (2018) Prognostic Role of Neutrophil to Lymphocyte Ratio in Ovarian Cancer: A Meta-Analysis. Technology in Cancer Research and Treatment. https://doi.org/10.1177/1533033818791500
R. Berardi, S. Rinaldi, M. Santoni, et al (2016) Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy. OncoTarget. https://doi.org/10.18632/oncotarget.8309
Ryo Sato, Takanori Suzuki, K. Matsuura, et al (2025) The Neutrophil-to-Lymphocyte Ratio during Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma Predicts Long-term Therapeutic Efficacy: A Multicenter Analysis. Oncology. https://doi.org/10.1159/000547264
M. Santoni, S. Buti, A. Conti, et al (2015) Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy. Targeted oncology. https://doi.org/10.1007/s11523-014-0356-3
WU J., WU X.-D., Y. Gao (2023) Correlation between preoperative systemic immune-inflammatory indexes and the prognosis of gastric cancer patients. European Review for Medical and Pharmacological Sciences. https://doi.org/10.26355/eurrev_202306_32811
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Putu Putri Andiyani Dewi, I Putu Candra Yogiswara (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
